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Abstract Electronic states of iron ion complexes in human blood from patients
with melanoma have been investigated by electron paramagnetic resonance (EPR).
The measurements were performed at liquid nitrogen temperature (77 K) on an
X-band EPR spectrometer. Numerous types of iron paramagnetic centers have been
identiﬁed. In several kinds of protein complexes exempliﬁed by methemoglobin,
transferrin or ferritin, various forms of trivalent iron have been found. Three groups
of patients with typical EPR spectra have been individualized. These groups dif-
fered in types and concentration of paramagnetic centers in peripheral blood. A
good correlation has been found between the EPR results, the total iron ion com-
plexes concentration and transferrin saturation.
1 Introduction
Electron paramagnetic resonance (EPR) is one of the most frequently applied
methods in structural investigations of paramagnetic particles, e.g., free radicals.
The EPR method makes possible the recording of the interaction between
electromagnetic radiations and investigated paramagnetic samples placed into the
magnetic ﬁeld [1]. It is characterized by high sensitivity, short time of measurement
and simple preparation of the paramagnetic samples. That is why it ﬁnds even wider
applications in the investigations of biological substances. With the help of EPR,
detection of the free radicals and investigations of the electronic states of various
ions and their complexes, including the iron ions, become possible.
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Magnetic ResonanceIron complexes are the elements widely proliferated in nature, indispensable for
almost all living organisms. The important role of iron in the metabolism is related
to its ability to oxidize and reduce. Maintaining the regular level of iron ions in the
body is extremely important since both its deﬁciency and overload can lead to
serious disorders. In the human body three to ﬁve gram of iron can be found. About
70% of this quantity is bound in blood, mainly in the form of hemoglobin (Hb),
about 25% is stored in proteins, ferritin and hemosiderin (stored pool), 3% is bound
to myoglobin (tissue pool), and about 2% is named serum pool, i.e., iron bound to
transferrin or solute iron. Gaining a thorough knowledge of the mechanism of iron
metabolism at the cell level has been made possible by the development of modern
technology. It enabled one also to investigate the effect of this element on regular
functioning of the body.
Both normal and neoplastic cells take up iron by endocytosis with the help of the
transferrin receptors. Some cells have the ability of iron uptake by adsorption
pinocytosis. However, the effectiveness of such a process is much lower [2]. Such a
characteristic reveal, i.e., the melanoma cells. This is a malignant neoplasm of skin
arising mostly within the melanocytic nevus. It stems from the pigment cells—
melanocytes—producing the melanin. It is characterized by a quick growth and
numerous metastases. At the melanoma cells, there occurs the p97 antigen termed
also melanotransferrin (MTf). It reveals a signiﬁcant homology with transferrin and
lactoferrin. Initially, MTf has been attributed an additional mechanism of iron
uptake by melanoma cells. However, it happens that while it is true that MTf binds
iron, it does not transfer this element to the interior of the cell. It has been also
ascertained that the MTf expression does not depend on the intracellular iron
concentration [3]. The mechanism of the iron concentration level-off during the
progress of the neoplastic disease is probably related to the presence of the released
proinﬂammatory cytokines and the production of the acute phase proteins. The
monocytes and cytokine macrophages IL-1, IL-6, TNF-a enhance the production of
ferritin, which is an iron-storing protein. At the same time, those cytokines induce a
reduction in the expression of transferrin receptors. This, in turn, reduces the iron
uptake through receptors and enhances the uptake of iron stemming from the cells
that turn to phagocytes [4, 5]. The accumulation of iron in the cells of the
reticuloendothelial system and in macrophages lowers the accessibility of iron for
the erythrocyte system, which can lead to a reduction in the Hb concentration and
anemia. Thus, understanding the role and functions of the of iron ion complexes in
the development of cancer seems to be very reasonable.
The aim of the current work is to investigate the electron states of iron ion
complexes in human blood by EPR spectroscopy and to check if the results obtained
in this way can be related to the results of standard biochemical laboratory
examinations of different blood elements.
2 Materials and Methods
Samples of whole blood have been collected from 20 patients with melanoma. All
people participated in the project to develop a vaccine against melanoma in the
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123Greater Poland Cancer Centre in Poznan ´. Blood collected from the patients was
subjected to laboratory examinations. The results are given in Table 1. The
following data have been determined: Hb concentration (mmol/l), iron concentra-
tion (Fe) (lg/dl), transferrin concentration (Tf) (g/l), total iron-binding capacity
(TIBC) (lg/dl), unbound iron-binding capacity (UIBC) (lg/dl), ferritin concentra-
tion (Ferr) (lg/l) and transferrin saturation (%).
Blood has also been collected from 20 healthy volunteers in order to observe the
differences between the spectra of healthy and ill persons.
Immediately after collecting blood, a part of the sample was injected to the
plastic phials prepared earlier and frozen in liquid nitrogen (77 K). The samples
were stored at 77 K for all time.
The measurements (at a temperature of 77 K) were performed on an X-band
Bruker EMX-10 EPR spectrometer operating at 9.4 GHz. The following settings
were used: microwave power, 20 mW; modulation frequency, 100 kHz; second
modulation amplitude, 1 mT.
3 Results and Discussion
For all except four examined patients, the blood laboratory data were contained
within the laboratory-speciﬁed norm. Two of the examined patients (patients Nos. 2
and 11 in Table 1) exhibited a slightly enhanced Hb level, whereas the female
patient No. 20 exhibited a largely enhanced level of iron in blood and an enhanced
value of the transferrin saturation (Table 1). One patient (No. 14 in Table 1)
exhibited a slightly lowered iron level.
The collected blood samples were subjected to EPR measurements. A typical
EPR spectrum of blood of healthy persons is shown in Fig. 1 and the exemplary
EPR spectra of blood from patients ill with melanoma are presented in Figs. 2 and 3.
On comparing the EPR spectra of healthy persons with those of patients ill with
melanoma one can say that in the case of healthy persons there occurs a much more
complex EPR spectrum with more lines coming from higher number of various
types of Fe
3? complexes than in those with melanoma. The EPR lines for healthy
people are also more intensive. For example, the EPR line amplitude at
g = 4.16–4.24 is higher for healthy persons (Fig. 1) than for patients with
melanoma (Figs. 2, 3). A similar dependence is observed for other lines. In case of
healthy persons, the line at g = 2.04, which is not observed in the spectrum of
patients with melanoma, was additionally registered. This line is probably derived
from copper ions contained in ceruloplasmin, which is the main copper transport
protein in blood [6].
The EPR spectra obtained for patients with melanoma differ both in the number
of components of the EPR lines composing the spectra and their parameters, e.g.,
intensity. (Figs. 2, 3; Table 2). In the current work, four different kinds of
components of the EPR spectra were individualized with g-factor amounting to:
g = 6.08–6.09, g = 4.14–4.22, g = 3.12, g = 2.34–2.39. The interpretation of EPR
of biological substances such as blood is not easy. The consequence of the presence
of numerous iron–protein complexes is that the position and structure of resonance
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123lines, apart from the content of paramagnetic complexes in blood, are affected also
by many factors such as the sample storage conditions, pH [7] or measurement
temperature [8].
It is commonly admitted that the signal at g = 6.0 is due to the trivalent heme
iron in methemoglobin (MetHb) [9–11] in which iron is at the third degree of
oxidation instead of the second one. Trivalent iron cannot bind oxygen, the energy
of the crystalline ﬁeld at the Fe
3? ion is small and iron is in the high-spin state
S = 5/2. A marginal percent of such Hb can be found in blood of every human. The
EPR line recorded at g = 4.14–4.22 represents a typical signal from the non-heme
iron Fe
3? ion in a system of low, rhombic symmetry in an octahedral or tetrahedral
surrounding. Such systems give rise to low crystalline ﬁelds, hence iron is in the
Fig. 1 EPR spectrum typical for a healthy person
Fig. 2 EPR spectrum typical for patients from group II
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123Fig. 3 EPR spectrum typical for patients from group III
Table 2 Values of the spectroscopic parameters calculated for all EPR spectra of patients with
melanoma
Patient’s
number
EPR signal amplitude
for g = 6.08–6.09
line (a.u.)
EPR signal amplitude
for g = 4.14–4.22
line (a.u.)
EPR signal
amplitude for
g = 3.12 line (a.u.)
EPR signal amplitude
for g = 2.36–2.39
line (a.u.)
1 0.8 1.35 – –
2 1.4 1.5 2.15 12.3
3 1.4 2.0 – 4.7
4 1.5 1.9 – 2.4
5 0.8 1.6 3.6 7.4
6 1.2 2.4 – –
7 0.55 0.9 – –
8 9.2 (g = 5.77) – – –
9 0.9 1.0 – –
10 0.9 1.95 – –
11 0.9 1.5 – 8.5
12 2.0 1.9 – –
13 1.0 1.1 – 15.1
14 0.7 1.4 – –
15 0.9 2.2 – –
16 0.8 2.2 – 8.3
17 – 1.9 – 4.3
18 0.85 1.8 – 19.0
19 0.9 1.9 – –
20 0.6 3.5 – –
The types of EPR spectra are discussed in text and shown in Figs. 2, 3
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123high-spin state S = 5/2. In some works [8, 9, 11, 18–20] this signal is a single peak
and in others [6, 7, 13, 17] it shows a complex. Most authors have interpreted this
signal as originating from Fe
3? in transferrin [7–9, 11–20]. Correlation of the signal
amplitude changes with the transferrin saturation appears to conﬁrm this interpre-
tation (Fig. 4).
The interpretation of the resonance lines at g = 3.12 and g = 2.34–2.39 is not
univocal. These signals are not derived from the EPR cavity or vial. Control EPR
spectra of the empty resonator with empty vials were made repeatedly and any
additional lines were recorded. They are related to various heme protein complexes
wherein iron is on the third degree of oxidation, the so-called hematin or hemin.
Contrary to the case of MetHb, iron in hemin is in the low-spin state. According to
the classiﬁcation proposed by Ann Walker [7, 16], one can distinguish three kinds of
signals originating in complexes of this type, depending on the positions of the
Fig. 4 Amplitude of the EPR signal as a function of the transferrin saturation for all investigated
patients, R
2 = 0.7985 a and for women, R
2 = 0.9298 b
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123histidine ligands axially attached to the iron ion. The signals at g = 3.12 and
g = 2.34–2.39 are probably from the type-II centers, where the ligands are
positioned parallel in the common plane. Such an arrangement causes an increase in
ﬁeld surrounding of the iron ion, which favors the low-spin state (considered as a
‘‘pure’’ low-spin system).
Depending on the type of the recorded EPR spectrum (Figs. 2, 3), patients were
divided into several groups.
The ﬁrst group characterized by the type-I EPR spectrum consisted of nine
patients: six women and three men (Table 1). Their corresponding spectra are
characterized by the presence of only two signals at g = 6.09 and g = 4.2. This
group reveals very diverse blood biochemical parameters. However, at the same
time high and much equalized TIBC level of 359 ± 30 (lg/dl) could be observed.
The accurate biochemical parameters are given in Table 1.
The second group consisted of patients with type-II EPR spectra (Fig. 2). Six
patients, ﬁve women and one man, belonged to this group. Their spectra are
characterized by three signals at g = 6.08, g = 4.21 and g = 2.36. All the persons
with such characteristic EPR spectra had a lowered level of iron in blood, on
average 78 (lg/dl), whereas the norm median is 97 (lg/dl) for women and men
taken together (Table 1).
In the case of patients No. 2 and No. 5 (Table 1), four lines in the EPR spectra at
g = 6.09, g = 4.16, g = 3.12 and g = 2.39 (Fig. 3) have been observed.
The EPR spectrum of patient No. 8 has a completely different character. An
intense line at g = 5.77 probably due to magnetic admixtures is seen.
The EPR spectrum recorded for patient No. 17 also differs from the ones
discussed above. Apart from the lines at g = 4.14 and g = 2.34, also an EPR line at
g = 8.10 has been recorded.
The spectrum for patient No. 7 shows only traces of EPR signals.
The biochemical parameters of the latter few patients do not show any deviations,
i.e., do not show signiﬁcant differences with respect to the remaining patients
(Table 1). They can be assigned to no particular group.
Depending on the EPR spectra type ascribed to a particular groups of patients, in
peripheral blood either a lack of certain Fe
3? complexes can be observed, such as
low-spin iron in ferriheme complexes, or high-spin iron in ferritin micelles.
The analysis of the recorded spectra, contrary to our expectations, did not reveal
signals due to the reactive oxygen species (ROS) in patient’s blood. It is possible
that the lifetime of the radicals was so short that applying of a spin trap is required in
order to register their presence.
Comparing the data collected in Tables 1 and 2 it was noticed that the signal at
g = 4.2 is highly correlated with the transferrin saturation level and iron
concentration. The correlations have been determined for both the whole pool of
patients and for particular groups of patients with the corresponding type of the EPR
spectrum ascribed. A classiﬁcation with respect to gender has also been applied. The
majority of the experimental results are well described by a linear function, which is
conﬁrmed by the values of the correlation coefﬁcients R
2. In the analysis, the spectra
of patients No. 7, 8 and 17 have not been taken into account since they deviated
strongly from linearity. Figure 4a, b shows the exemplary relations obtained.
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123The coefﬁcients R
2 most close to unity are obtained for dependences for patients
of group I with the type-I spectra. Both transferrin saturation and iron concentration
dependences only very slightly deviate from linearity. For group I, the classiﬁcation
with respect to gender did not signiﬁcantly affect the changes in the coefﬁcient R
2
when compared with that of the whole group. On the contrary, this classiﬁcation
applied to patients with the type-II spectra, where the value of the coefﬁcient R
2
signiﬁcantly improved: in the case of transferrin saturation R
2 = 0.6136 for the
whole group and it has changed to R
2 = 0.9918 for women. On the other hand, in
the case of iron concentration it has changed from R
2 = 0.6275 to R
2 = 0.7570,
respectively. The dependence for men has not been determined due to a small
number of male patients qualiﬁed to this group. However, not all determined
dependences are linear. In the case of plots for men in the whole pool of patients, it
would be hard to ﬁnd such relations. In this case, the correlation coefﬁcients for iron
concentration amount to R
2 = 0.6607, although for transferrin saturation the
corresponding value is R
2 = 0.4330.
The correlation of the signal amplitude at g = 4.2 with the iron concentration in
blood and the transferrin saturation (deﬁned as the quotient of the iron concentration
in blood and TIBC) indicates to the fact that this resonance line comes just from the
iron ions contained in transferrin. The remaining biochemical parameters of blood
are not reﬂected in the spectra obtained. In the case of some patients, EPR signals of
large widths of the order of several hundreds gauss and g-factor g  2.0 have been
observed. These signals come probably from the iron Fe
3? ion complexes forming
structures of various degrees of magnetic ordering.
4 Conclusion
The existence of a correlation of the iron ion concentration in blood and transferrin
saturation with the amplitude of the EPR line at g = 4.2 has been determined. This
line is a typical signal from the non-heme iron Fe
3? ion in a system of low, rhombic
symmetry in an octahedral or tetrahedral surrounding.
Only in healthy people the complexes of copper Cu
2? were observed.
EPR signals recorded for healthy people show more different types and higher
concentration of paramagnetic species than those in patients with melanoma.
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